Prostate Cancer Canada (PCC)
Cancer de la Prostate Canada (PCC)

Canada

1 September 2020 - 31 August 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Prostate Cancer Canada (PCC) published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0
Physical Sciences 1 0

Top articles by Altmetric score in current window

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Nature Communications

2020-09-21

1 September 2020 - 31 August 2021

International vs. domestic collaboration by Share

  • 9.59% Domestic
  • 90.41% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (22 total)

  • Prostate Cancer Canada (PCC), Canada
  • Domestic institution
  1. Ontario Institute for Cancer Research (OICR), Canada (0.05)
    0
    0.05
  2. University of Toronto (U of T), Canada (0.02)
    0
    0.02
  3. Provincial Health Services Authority (PHSA), Canada (0.02)
    0
    0.02
  4. McGill University and Génome Québec Innovation Centre, Canada (0)
    0
    0
  5. Vancouver Prostate Centre (VPC), Canada (0)
    0
    0
  6. McGill University, Canada (0)
    0
    0
  7. The University of British Columbia (UBC), Canada (0)
    0
    0
  8. Axela Inc., Canada (0)
    0
    0
  9. Simon Fraser University (SFU), Canada (0)
    0
    0
  10. Genome Canada, Canada (0)
    0
    0

Top 10 international collaborators by Share (405 total)

  • Prostate Cancer Canada (PCC), Canada
  • Foreign institution
  1. Harvard University, United States of America (USA) (0.04)
    0
    0.04
  2. Wellcome Sanger Institute, United Kingdom (UK) (0.03)
    0
    0.03
  3. Helmholtz Association of German Research Centres, Germany (0.03)
    0
    0.03
  4. Broad Institute of MIT and Harvard, United States of America (USA) (0.03)
    0
    0.03
  5. University Hospital of Verona, Italy (0.03)
    0
    0.03
  6. European Molecular Biology Laboratory (EMBL), Germany (0.03)
    0
    0.02
  7. The University of North Carolina at Chapel Hill (UNC), United States of America (USA) (0.02)
    0
    0.02
  8. Washington University in St. Louis (WUSTL), United States of America (USA) (0.02)
    0
    0.02
  9. National Institutes of Health (NIH), United States of America (USA) (0.02)
    0
    0.02
  10. The University of Texas MD Anderson Cancer Center, United States of America (USA) (0.02)
    0
    0.02

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Prostate Cancer Canada (PCC)

Affiliated joint institutions and consortia

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER